N4 Pharma (N4P)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.41p
   
  • Change Today:
    -0.011p
  • 52 Week High: 3.07
  • 52 Week Low: 0.40
  • Currency: UK Pounds
  • Shares Issued: 537.56m
  • Volume: 307,280
  • Market Cap: £2.23m
2016-10-17 - Suspension of Listing

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -71250.0% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 1142.3 n/a
Pr/Book 1.9  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

N4 Pharma Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 n/a (0.95) (0.87)p n/a n/a n/a n/a 0.0%
31-Dec-20 n/a (1.57) (0.96)p n/a n/a n/a n/a 0.0%
31-Dec-21 n/a (1.84) (0.85)p n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (1.19) (0.55)p n/a n/a n/a n/a 0.0%
31-Dec-23 n/a (1.42) (0.52)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

N4 Pharma Company Announcements

Posting of Circular and Notice of General Meeting 04-Apr-2025 07:08 RNS
Placing and Subscription to raise £1,750,000 01-Apr-2025 16:08 RNS
Holding(s) in Company 18-Feb-2025 12:34 RNS

Latest N4 Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

N4 Pharma Market Data

Currency UK Pounds
Share Price 0.41p
Change Today -0.011p
% Change -2.52 %
52 Week High 3.07
52 Week Low 0.40
Volume 307,280
Shares Issued 537.56m
Market Cap £2.23m

N4 Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
38% below the market average38% below the market average38% below the market average38% below the market average38% below the market average
37.5% below the sector average37.5% below the sector average37.5% below the sector average37.5% below the sector average37.5% below the sector average
Value
38% below the market average38% below the market average38% below the market average38% below the market average38% below the market average
37.5% below the sector average37.5% below the sector average37.5% below the sector average37.5% below the sector average37.5% below the sector average
Income Not Available
Growth Not Available

N4 Pharma Dividends

No dividends found

Trades for 07-Apr-2025

Time Volume / Share Price
10:07 285,173 @ 0.44p
09:53 500 @ 0.45p
09:53 14,000 @ 0.40p
09:53 184 @ 0.45p
08:21 6,006 @ 0.40p

N4 Pharma Key Personnel

CEO Nigel Theobald

Top of Page